Agios Pharmaceuticals, Inc. (AGIO) revenue

Revenue · fiscal 2025
$54.03M

Agios Pharmaceuticals, Inc. (AGIO) reported revenue of $54.03M in fiscal 2025 (the year ended December 31, 2025). That is 48.0% higher than the $36.50M of fiscal 2024. Figures as of 18 Nov 2026, 10:37 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$54.03M
Change on fiscal 2024
+48.0%
Growth, 10 years
−0.9% a year
Highest on record
$117.91Mfiscal 2019
Lowest on record
$14.24Mfiscal 2022
Fiscal years on record
132011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Agios Pharmaceuticals, Inc. revenue, in more detail

Over the ten fiscal years to 2025 revenue shrank at a compound 0.9% a year. Across the 13 fiscal years on record (2011–2025), the highest was $117.91M in fiscal 2019 and the lowest $14.24M in fiscal 2022.

History · 13 fiscal years

Revenue by fiscal year

Agios Pharmaceuticals, Inc. revenue, year by year

Agios Pharmaceuticals, Inc. (AGIO) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$54.03M 48.0% up
2024$36.50M 36.1% up
2023$26.82M 88.4% up
2022$14.24M—
2019$117.91M 24.9% up
2018$94.39M 119.4% up
2017$43.01M 38.5% down
2016$69.89M 18.2% up
2015$59.12M 9.5% down
2014$65.36M 155.8% up
2013$25.55M 1.8% up
2012$25.11M 15.0% up
2011$21.84M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on AGIO

Agios Pharmaceuticals, Inc., figure by figure

Agios Pharmaceuticals, Inc. (AGIO) overview: price, valuation and scorecard

Agios Pharmaceuticals, Inc. revenue: questions and answers

What is Agios Pharmaceuticals, Inc.'s revenue?

Agios Pharmaceuticals, Inc. (AGIO) reported revenue of $54.03M in fiscal 2025 (the year ended December 31, 2025). That is 48.0% higher than the $36.50M of fiscal 2024.

What is the growth rate of Agios Pharmaceuticals, Inc.'s revenue?

Over the ten fiscal years to 2025 revenue shrank at a compound 0.9% a year.

What are the highest and lowest revenue figures on record for Agios Pharmaceuticals, Inc.?

Across the 13 fiscal years on record (2011–2025), the highest was $117.91M in fiscal 2019 and the lowest $14.24M in fiscal 2022.

How is Agios Pharmaceuticals, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Agios Pharmaceuticals, Inc. it is on record here for 13 fiscal years, 2011 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Agios Pharmaceuticals, Inc. (AGIO) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/AGIO/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.